US Stock MarketDetailed Quotes

MDNAF Medicenna Therapeutics

Watchlist
  • 1.720
  • +0.060+3.61%
15min DelayTrading Oct 15 13:56 ET
131.46MMarket Cap-6254P/E (TTM)

Medicenna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.87%-2.33M
-28.47%-16.26M
-111.48%-4.85M
-10.09%-4.03M
10.95%-3.92M
-50.39%-3.47M
46.33%-12.66M
20.92%-2.29M
46.05%-3.66M
52.84%-4.4M
Net income from continuing operations
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
Operating gains losses
94.26%-72K
257.48%8.24M
647.08%10.38M
102.12%73K
68.14%-960K
-646.43%-1.25M
-4,422.31%-5.23M
--1.39M
---3.44M
-4,266.67%-3.01M
Depreciation and amortization
400.00%5K
0.00%4K
0.00%1K
0.00%1K
-50.00%1K
--1K
-89.47%4K
-87.50%1K
-90.00%1K
-80.00%2K
Other non cash items
----
15.46%-984K
----
----
----
-163.64%-29K
-57.94%-1.16M
-49.50%-1.04M
-170.00%-27K
-112.65%-84K
Change In working capital
148.16%943K
-69.25%741K
-180.35%-822K
18.09%718K
155.23%465K
-76.56%380K
230.69%2.41M
33.03%1.02M
125.38%608K
61.22%-842K
-Change in receivables
-123.02%-218K
36.31%1.68M
60.38%340K
-1.80%546K
90.50%-155K
-54.80%947K
414.03%1.23M
-56.38%212K
-18.11%556K
38.39%-1.63M
-Change in payables and accrued expense
304.76%1.16M
-179.47%-937K
-243.28%-1.16M
230.77%172K
-21.52%620K
-19.62%-567K
181.20%1.18M
186.57%811K
101.69%52K
65.27%790K
Cash from discontinued investing activities
Operating cash flow
32.87%-2.33M
-28.47%-16.26M
-111.48%-4.85M
-10.09%-4.03M
10.95%-3.92M
-50.39%-3.47M
46.33%-12.66M
20.92%-2.29M
46.05%-3.66M
52.84%-4.4M
Investing cash flow
Cash flow from continuing investing activities
-31K
0
Net PPE purchase and sale
---31K
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---31K
----
----
----
----
--0
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
20.9M
0
0
0
0
0
538.47%24.76M
-322.35%-189K
-96.09%136K
38,988.52%23.84M
Net common stock issuance
--19.71M
--0
--0
--0
--0
--0
605.61%24.76M
--0
-101.56%-53K
--23.84M
Proceeds from stock option exercised by employees
--1.18M
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--20.9M
--0
--0
--0
--0
--0
538.47%24.76M
-322.35%-189K
-96.09%136K
38,988.52%23.84M
Net cash flow
Beginning cash position
-49.45%16.98M
63.60%33.6M
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
-32.40%20.54M
54.55%36.15M
139.73%40.01M
-25.49%19.3M
Current changes in cash
634.54%18.54M
-234.35%-16.26M
-95.36%-4.85M
-14.34%-4.03M
-120.17%-3.92M
-159.39%-3.47M
225.34%12.1M
11.81%-2.48M
-152.50%-3.52M
309.58%19.44M
Effect of exchange rate changes
121.25%109K
-136.95%-354K
189.61%69K
128.96%97K
-100.55%-7K
-588.57%-513K
620.65%958K
-71.11%-77K
-8,275.00%-335K
2,081.03%1.27M
End cash Position
20.31%35.63M
-49.45%16.98M
-49.45%16.98M
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
54.55%36.15M
139.73%40.01M
Free cash flow
31.98%-2.36M
-28.47%-16.26M
-111.48%-4.85M
-10.09%-4.03M
10.95%-3.92M
-50.39%-3.47M
46.33%-12.66M
20.92%-2.29M
46.05%-3.66M
52.84%-4.4M
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.87%-2.33M-28.47%-16.26M-111.48%-4.85M-10.09%-4.03M10.95%-3.92M-50.39%-3.47M46.33%-12.66M20.92%-2.29M46.05%-3.66M52.84%-4.4M
Net income from continuing operations -27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K
Operating gains losses 94.26%-72K257.48%8.24M647.08%10.38M102.12%73K68.14%-960K-646.43%-1.25M-4,422.31%-5.23M--1.39M---3.44M-4,266.67%-3.01M
Depreciation and amortization 400.00%5K0.00%4K0.00%1K0.00%1K-50.00%1K--1K-89.47%4K-87.50%1K-90.00%1K-80.00%2K
Other non cash items ----15.46%-984K-------------163.64%-29K-57.94%-1.16M-49.50%-1.04M-170.00%-27K-112.65%-84K
Change In working capital 148.16%943K-69.25%741K-180.35%-822K18.09%718K155.23%465K-76.56%380K230.69%2.41M33.03%1.02M125.38%608K61.22%-842K
-Change in receivables -123.02%-218K36.31%1.68M60.38%340K-1.80%546K90.50%-155K-54.80%947K414.03%1.23M-56.38%212K-18.11%556K38.39%-1.63M
-Change in payables and accrued expense 304.76%1.16M-179.47%-937K-243.28%-1.16M230.77%172K-21.52%620K-19.62%-567K181.20%1.18M186.57%811K101.69%52K65.27%790K
Cash from discontinued investing activities
Operating cash flow 32.87%-2.33M-28.47%-16.26M-111.48%-4.85M-10.09%-4.03M10.95%-3.92M-50.39%-3.47M46.33%-12.66M20.92%-2.29M46.05%-3.66M52.84%-4.4M
Investing cash flow
Cash flow from continuing investing activities -31K0
Net PPE purchase and sale ---31K------------------0----------------
Cash from discontinued investing activities
Investing cash flow ---31K------------------0----------------
Financing cash flow
Cash flow from continuing financing activities 20.9M00000538.47%24.76M-322.35%-189K-96.09%136K38,988.52%23.84M
Net common stock issuance --19.71M--0--0--0--0--0605.61%24.76M--0-101.56%-53K--23.84M
Proceeds from stock option exercised by employees --1.18M------------------0----------------
Cash from discontinued financing activities
Financing cash flow --20.9M--0--0--0--0--0538.47%24.76M-322.35%-189K-96.09%136K38,988.52%23.84M
Net cash flow
Beginning cash position -49.45%16.98M63.60%33.6M-39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M-32.40%20.54M54.55%36.15M139.73%40.01M-25.49%19.3M
Current changes in cash 634.54%18.54M-234.35%-16.26M-95.36%-4.85M-14.34%-4.03M-120.17%-3.92M-159.39%-3.47M225.34%12.1M11.81%-2.48M-152.50%-3.52M309.58%19.44M
Effect of exchange rate changes 121.25%109K-136.95%-354K189.61%69K128.96%97K-100.55%-7K-588.57%-513K620.65%958K-71.11%-77K-8,275.00%-335K2,081.03%1.27M
End cash Position 20.31%35.63M-49.45%16.98M-49.45%16.98M-39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M54.55%36.15M139.73%40.01M
Free cash flow 31.98%-2.36M-28.47%-16.26M-111.48%-4.85M-10.09%-4.03M10.95%-3.92M-50.39%-3.47M46.33%-12.66M20.92%-2.29M46.05%-3.66M52.84%-4.4M
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data